Oncology
 |
|
13 october 2018 17:00:06 |
| The promise of ESCAT: a new system for evaluating cancer drug-target pairs (Nature Clinical Practice Oncology) |
|
Tweet |
| 101 viewsCategory: Oncology |
 Oncogenic mRNA modification explained (Nature Reviews Cancer)Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
